{"provider": "google_genai", "model": "gemini-flash-lite-latest", "text": "{\"grade\": 0, \"reasoning\": \"The criterion specifically asks if the response suggests the UK can claim Patent Box relief on its \\\"CSA share\\\" (e.g., its 30% contribution) within the context of a Cost Contribution Arrangement (CCA). The candidate answer does not mention Cost Contribution Arrangements (CCA), Patent Box relief, or claiming relief on a 'CSA share'. Instead, it recommends a full substance migration model where the UK becomes a routine service provider remunerated on a cost-plus/TNMM basis, which is a different framework entirely.\", \"criterion_id\": \"43cc9d52-aab4-439e-9d4e-51dd3f4c2a07\"}", "usage": {"prompt_tokens": 1527, "completion_tokens": 156, "total_tokens": 1683}, "latency_s": 0.5822335000266321, "request_id": "tRyVad7uH9qgkdUPg_fLkAM", "raw_response": null}